Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age18+
SponsorAtlantic Health System

About this trial

The current American College of Cardiology/American Heart Association (ACC/AHA) guidelines recommend surgery in patient with mitral regurgitation (MR) based on 1) the severity of MR and 2) the presence or absence of symptoms. Studies have shown that Cardiovascular Magnetic Resonance (CMR) is an accurate method to quantify the severity of MR. However, studies have also shown that symptoms are not necessarily related to the presence of symptoms. Thus, there appears to be a disconnect between the severity of MR and symptoms. Recent analysis of our data has shown that females and older patients with smaller ventricles, lower stroke volumes, and lower regurgitant volume relative to regurgitant fraction tend to be symptomatic. These findings suggest that decreased left ventricular compliance, i.e. diastolic dysfunction, may play an important role as an etiology of symptoms in patients with mitral regurgitation. The aim of this study is to study the presence of diastolic dysfunction in patients with MR and its association with symptom burden and exercise capacity.

Eligibility criteria

Qualifiers

Age >=18 years of age

Able to give informed consent

Primary (degenerative) mitral regurgitation

LVEF >=50%

Disqualifiers

Unable to give informed consent

Secondary (functional) mitral regurgitation

LVEF <50%

Known coronary artery stenosis >=70% or past revascularization

Trial design

Treatments tested in this trial

  • Pressure volume loop evaluation
  • cardiovascular magnetic resonance imaging
  • Cardiopulmonary exercise testing (CPET)
  • Kansas City Cardiomyopathy Questionairre

Treatment groups

40 Participants
are divided into 1 treatment group

Sponsors and collaborators